Want to see TSE:TGIF full AI Analyst Report?
Top Page
1933 Industries
(TGIF)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.01
▲(0.00% Upside)
Action:Reiterated
Date:07/01/26
The score is held down primarily by financial risk: negative equity, high leverage, and weak operating profitability (negative operating profit/EBITDA) outweigh the recent improvement to positive net income and positive free cash flow. Technicals also lean bearish with the stock trading below key moving averages. Valuation is a partial offset due to the very low P/E, but it is not enough to overcome the balance-sheet and operating concerns.
Positive Factors
Improving cash generation
Consistent positive free cash flow and operating cash flow indicate the business can internally fund some operations and capital needs. This strengthens near-term self-financing ability, supports earnings quality, and reduces absolute reliance on external financing if cash conversion momentum stabilizes.
Negative Factors
Weak balance sheet / negative equity
Negative equity and sizable debt relative to assets materially constrain financial flexibility and increase solvency risk. This structure leaves the company vulnerable to cash-flow volatility, limits ability to raise unsecured capital, and raises default or restructuring risk if performance weakens.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving cash generation
Consistent positive free cash flow and operating cash flow indicate the business can internally fund some operations and capital needs. This strengthens near-term self-financing ability, supports earnings quality, and reduces absolute reliance on external financing if cash conversion momentum stabilizes.
Read all positive factors
1933 Industries (TGIF) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$2.60M
Dividend YieldN/A
Average Volume (3M)196.77K
Price to Earnings (P/E)3.1
Beta (1Y)-1.89
Revenue Growth-4.90%
EPS GrowthN/A
CountryCA
Employees85
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)<0.01
Shares Outstanding520,763,200
10 Day Avg. Volume47,183
30 Day Avg. Volume196,769
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)-1.07
Price to Sales (P/S)0.28
P/FCF Ratio2.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
1933 Industries Business Overview & Revenue Model
Company Description
1933 Industries Inc. is a Vancouver, Canada-based cannabis company engaged in the cultivation and production of cannabis products throughout the United States and Canada. The firm develops, packages, and markets an extensive range of cannabidiol (...
How the Company Makes Money
1933 Industries makes money primarily by selling cannabis products through regulated, state-licensed cannabis supply chains. Key revenue streams include: (1) wholesale and/or direct sales of company-produced cannabis products (including manufactur...
1933 Industries Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
18
Very Negative
Cash Flow
57
Neutral
| Breakdown | TTM | Oct 2025 | Jan 2025 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.51M | 17.45M | 19.35M | 18.27M | 12.54M | 11.98M |
| Gross Profit | 169.46K | 5.16M | 2.94M | -4.22M | 2.69M | 4.82M |
| EBITDA | -2.02M | 1.01M | 313.67K | -10.03M | -13.83M | -2.71M |
| Net Income | 468.28K | -217.04K | -1.14M | -13.36M | -18.07M | -6.29M |
Balance Sheet | ||||||
| Total Assets | 15.53M | 16.80M | 16.87M | 18.02M | 29.01M | 45.35M |
| Cash, Cash Equivalents and Short-Term Investments | 536.57K | 545.98K | 449.18K | 1.09M | 363.27K | 4.41M |
| Total Debt | 15.57M | 17.60M | 16.78M | 17.57M | 17.68M | 17.87M |
| Total Liabilities | 18.80M | 21.40M | 21.70M | 23.28M | 21.49M | 20.12M |
| Stockholders Equity | -3.27M | -4.60M | -3.53M | -3.69M | 8.52M | 25.99M |
Cash Flow | ||||||
| Free Cash Flow | 1.91M | 1.67M | 801.71K | -2.33M | -5.10M | -5.12M |
| Operating Cash Flow | 2.08M | 1.84M | 1.69M | -1.53M | -5.09M | -4.67M |
| Investing Cash Flow | -318.84K | -169.22K | -890.78K | 2.33M | 1.58K | -456.36K |
| Financing Cash Flow | -2.02M | -1.58M | -1.46M | -266.55K | 1.53M | 6.06M |
1933 Industries Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | C$7.43M | -8.82 | -332.63% | ― | -36.67% | 40.54% | |
45 Neutral | C$2.60M | 3.13 | -11.60% | ― | -4.90% | ― | |
41 Neutral | C$3.44M | -3.40 | -26.42% | ― | -10.74% | -559.18% | |
41 Neutral | C$11.21M | -3.21 | 28.59% | ― | 0.90% | 57.73% |
* Healthcare Sector Average
TSE:TGIF
1933 Industries
0.01
0.00
0.00%
TSE:DHB
Delivra Health Brands
0.11
-0.09
-45.81%
TSE:BBM
Blueberries Medical
0.02
0.00
0.00%
TSE:PCLO
PharmaCielo
0.06
0.02
33.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.